By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agenus (Formerly known as Antigenics Inc. - New York) 

Corporate Headquarters
3 Forbes Road
Lexington  Massachusetts  02421-7305  U.S.A.
Phone: 781-674-4400 Fax: 781-674-4200


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
Agenus (AGEN) Reports Second Quarter 2014 Financial Results 7/24/2014 11:23:32 AM
Massachusetts' Agenus (AGEN) Touts Positive Phase 2 Data From HerpV Study 6/26/2014 6:02:11 AM
Agenus (Formerly known as Antigenics Inc. - New York) (AGEN) Completes Acquisition of 4-Antibody AG 2/13/2014 8:16:39 AM
Agenus (Formerly known as Antigenics Inc. - New York) (AGEN)’ Prophage Vaccine For Glioma Hailed As A "Very Promising Therapy" In An Editorial Published In The Journal Neuro-Oncology 1/21/2014 9:11:33 AM
Agenus (Formerly known as Antigenics Inc. - New York) (AGEN) To Present At OneMedForum San Francisco 2014 1/9/2014 7:01:29 AM
Agenus (Formerly known as Antigenics Inc. - New York) (AGEN)' Brain Cancer Vaccine Program Named A "Top Project To Watch" By Elsevier Business Intelligence 11/18/2013 9:55:46 AM
Agenus Reports Third Quarter 2013 Financial Results 10/24/2013 7:02:17 AM
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Reports Positive Follow-on Phase 2 Results for Brain Cancer Vaccine in Newly Diagnosed Patients 9/17/2013 10:57:34 AM
New Phase 2 Data From Brain Cancer Study With Agenus (Formerly known as Antigenics Inc. - New York) (AGEN)' Prophage Vaccine (HSPPC-96) Presented at Plenary Session of AANS 4/17/2012 9:41:30 AM
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines 12/20/2011 8:51:33 AM
12345678910...
//-->